Analysis for WELL
- 📈 Growth — 28/30
- 💰 Profitability — 16/20
- 🏦 Financial Health — 18/20
- 💵 Valuation — 12/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
Over 8 quarters, WELLTOWER's revenue rose from about $1.86B in 2024-Q1 to about $3.35B in 2026-Q1, roughly an 80% increase. Net income grew from about $131.6M to about $752.3M (continuing operations after tax), signaling durable earnings expansion despite quarterly fluctuations. Gross profit advanced from $762.8M to $1.30B, with margins generally in the high 30s to low 40s, supporting rising operating income.
💰 Margins & Cash Flow
Gross margin hovered around 39–41%. Operating income remained positive across quarters as costs were well managed. Net cash flow from operating activities stayed positive in most quarters, e.g., $670.0M in 2026-Q1. Investing activity was a recurring cash outflow, leading to negative quarterly total cash flow in several periods; financing flows varied and helped liquidity.
🛡️ Balance Sheet & Liquidity
Balance sheet strength is evident: current assets near $60–67B against current liabilities around $17–24B, implying a robust current ratio. Equity attributable to parent is typically in the mid‑to‑high teens to mid‑$40B range, and long‑term debt around $18–$20B. In Q1 2026, total assets were about $67.2B, current liabilities about $22.3B, and equity about $44.7B, with debt support from a strong asset base. This structure supports liquidity and resilience across cycles.
⚠️ Key Drivers & Risks
- Drivers: Aging population drives demand for healthcare real estate; long‑term leases and stable occupancy underpin recurring rental income.
- Risks: Interest‑rate sensitivity and real estate cycles; occupancy/renewal volatility and valuation sensitivity to rate moves.